Answers are grounded in this paper and cite their sources.
Glioblastoma is clinically and molecularly heterogeneous, yet whether its position relative to the lateral ventricles shapes tumour biology remains unclear. Here we measured tumour ventricle distance in 57 patients with IDH-wildtype glioblastoma and combined survival analysis with RNA sequencing, whole-genome sequencing, proteomics and multiplex immunofluorescence. Proximity to the ventricles was associated with shorter survival. Ventricle-proximal tumours lacked a distinct genomic driver but displayed an inflammatory yet immunoregulatory profile: antigen-presentation, leukocyte-activation and cytokine programmes coexisted with checkpoint and immunosuppressive transcripts, and proteomics revealed concordant complement and myeloid signals. In tissue, these tumours tended to show more Ki67-positive cells and proliferating SOX2-positive stem-like cells, suggesting increased plasticity of the stem-like compartment, without more CD4- or CD8a-positive lymphocytes. Ventricular proximity thus marks a clinically adverse context with a distinct immune-inflammatory profile, providing a framework for validation and patient stratification.
No takes yet. Share an insight, caveat, or question.
Gutiérrez-Arroyo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: